These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

94 related articles for article (PubMed ID: 7536437)

  • 1. Immunosuppressive therapy for vasculitis.
    Hall S; Conn DL
    Curr Opin Rheumatol; 1995 Jan; 7(1):25-9. PubMed ID: 7536437
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Systemic vasculitis: still a challenging disease.
    Buhaescu I; Covic A; Levy J
    Am J Kidney Dis; 2005 Aug; 46(2):173-85. PubMed ID: 16112036
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Hepatitis C virus acute quadriparetic vasculitic neuropathy responsive to cyclophosphamide.
    Souayah N; Sander HW; Menkes DL; Khella SL
    Neurol Neurophysiol Neurosci; 2006 Sep; ():5. PubMed ID: 17260082
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Stem cell transplantation in primary systemic vasculitis].
    Hensel M; Fiehn C; Ho AD
    Med Klin (Munich); 2003 Jan; 98(1):13-8. PubMed ID: 12540989
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Treatment of vasculitic peripheral neuropathy: a retrospective analysis of outcome.
    Mathew L; Talbot K; Love S; Puvanarajah S; Donaghy M
    QJM; 2007 Jan; 100(1):41-51. PubMed ID: 17189246
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Future studies of combination therapy for chronic hepatitis C: optimizing response rates for each hepatitis C population.
    Main J
    J Hepatol; 1995; 23 Suppl 2():32-5; discussion 35-6. PubMed ID: 8720292
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Systemic vasculitis treatment and monitoring update, 2008.
    Yazici Y
    Bull NYU Hosp Jt Dis; 2008; 66(3):228-30. PubMed ID: 18937637
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Newer therapies for vasculitis.
    Hiemstra TF; Jayne D
    Best Pract Res Clin Rheumatol; 2009 Jun; 23(3):379-89. PubMed ID: 19508945
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Optimizing the therapeutic strategies in ANCA-associated vasculitis--single centre experience with international randomized trials.
    Vanková Z; Ríhová Z; Jancová E; Rysavá R; Merta M; Tesar V
    Prague Med Rep; 2006; 107(2):199-212. PubMed ID: 17066740
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Cutaneous vasculitis: diagnosis and management.
    Carlson JA; Cavaliere LF; Grant-Kels JM
    Clin Dermatol; 2006; 24(5):414-29. PubMed ID: 16966021
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Clinical review: Vasculitis on the intensive care unit -- part 2: treatment and prognosis.
    Semple D; Keogh J; Forni L; Venn R
    Crit Care; 2005 Apr; 9(2):193-7. PubMed ID: 15774077
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Evidence-based management of ANCA vasculitis.
    Carruthers D; Sherlock J
    Best Pract Res Clin Rheumatol; 2009 Jun; 23(3):367-78. PubMed ID: 19508944
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Treatment of patients with Wegener's granulomatosis or ANCA-associated vasculitis].
    Tervaert JW; Stegeman CA
    Ned Tijdschr Geneeskd; 2003 Nov; 147(46):2265-7. PubMed ID: 14655291
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Treatment of viral vasculitis].
    Lhote F; Guillevin L
    Pathol Biol (Paris); 1999 Mar; 47(3):257-64. PubMed ID: 10214619
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Treatment of systemic vasculitides].
    Guillevin L; Pagnoux C
    Rev Prat; 2008 Mar; 58(5):541-4. PubMed ID: 18524111
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Review article: Progress of treatment in ANCA-associated vasculitis.
    Jayne D
    Nephrology (Carlton); 2009 Feb; 14(1):42-8. PubMed ID: 19335843
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Treatment of hepatitis C after liver transplantation].
    Samuel D; Roche B; Feray C
    Gastroenterol Clin Biol; 2002 Apr; 26 Spec No 2():B231-7. PubMed ID: 12180295
    [No Abstract]   [Full Text] [Related]  

  • 18. Activation of chronic hepatitis C virus infection by cyclophosphamide in a patient with cANCA-positive vasculitis.
    Arend SM; Hagen EC; Kroes AC; Bruijn JA; van der Woude FJ
    Nephrol Dial Transplant; 1995; 10(6):884-7. PubMed ID: 7566624
    [No Abstract]   [Full Text] [Related]  

  • 19. Randomized trial of cyclophosphamide versus methotrexate for induction of remission in early systemic antineutrophil cytoplasmic antibody-associated vasculitis.
    De Groot K; Rasmussen N; Bacon PA; Tervaert JW; Feighery C; Gregorini G; Gross WL; Luqmani R; Jayne DR
    Arthritis Rheum; 2005 Aug; 52(8):2461-9. PubMed ID: 16052573
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Long-term outcomes of patients with propylthiouracil-induced anti-neutrophil cytoplasmic auto-antibody-associated vasculitis.
    Gao Y; Chen M; Ye H; Yu F; Guo XH; Zhao MH
    Rheumatology (Oxford); 2008 Oct; 47(10):1515-20. PubMed ID: 18676500
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.